Role of GSK-3β in Regulation of Canonical Wnt/β-catenin Signaling and PI3-K/Akt Oncogenic Pathway in Colon Cancer

被引：54
作者：
Jain, Shelly [1 ]
Ghanghas, Preety [1 ]
Rana, Chandan [1 ]
Sanyal, S. N. [1 ]
机构：
[1] Panjab Univ, Dept Biophys, Chandigarh 160014, India
来源：
CANCER INVESTIGATION | 2017年 / 35卷 / 07期
关键词：
Akt; beta-catenin; colorectal cancer; DMH; GSK-3; beta; PI3-K; NITRIC-OXIDE SYNTHASE; ABERRANT CRYPT FOCI; BETA-CATENIN; PHOSPHATIDYLINOSITOL; 3-KINASE/AKT; CYCLOOXYGENASE-2; INHIBITOR; COLORECTAL-CANCER; DOWN-REGULATION; APOPTOSIS; CELECOXIB; DICLOFENAC;
D O I：
10.1080/07357907.2017.1337783
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Non-steroidal anti-inflammatory drugs (NSAIDs) are emerging as novel chemopreventive agents because of their ability in blocking cellular proliferation, and thereby tumor development, and also by promoting apoptosis. GSK-3 beta, a serine threonine kinase and a negative regulator of the oncogenic Wnt/beta-catenin signaling pathway, plays a critical role in the regulation of oncogenesis. Celecoxib and etoricoxib, the two cyclooxygenase-2 (COX-2) selective NSAIDs, and Diclofenac, a preferential COX-2 inhibitory NSAID, had shown uniformly the chemopreventive and anti-neoplastic effects in the early stage of colon cancer by promoting apoptosis as well as an over-expression of GSK-3 beta while down-regulating the PI3-K/Akt oncogenic pathway.
引用
收藏
页码：473 / 483
页数：11
相关论文
共 38 条
  • [1] [Anonymous], 2012, BIOMED PREV NUTR
  • [2] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [3] Role of phosphatidylinositol 3-kinase/AKT as a survival pathway against CYP2E1-dependent toxicity
    Caro, AA
    Cederbaum, AI
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (01) : 360 - 372
  • [4] PTEN and the PI3-Kinase Pathway in Cancer
    Chalhoub, Nader
    Baker, Suzanne J.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 : 127 - 150
  • [5] The renaissance of GSK3
    Cohen, P
    Frame, S
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) : 769 - 776
  • [6] Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3-methylimidazo[4,5-f]quinoline and treated postinitiation with chlorophyllin
    Dashwood, RH
    Xu, M
    Orner, GA
    Horio, DT
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (02) : 139 - 145
  • [7] Targeting PI3K signalling in cancer: opportunities, challenges and limitations
    Engelman, Jeffrey A.
    [J]. NATURE REVIEWS CANCER, 2009, 9 (08) : 550 - 562
  • [8] PI3K/Akt and apoptosis: size matters
    Franke, TF
    Hornik, CP
    Segev, L
    Shostak, GA
    Sugimoto, C
    [J]. ONCOGENE, 2003, 22 (56) : 8983 - 8998
  • [9] Diclofenac: an update on its mechanism of action and safety profile
    Gan, Tong J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1715 - 1731
  • [10] Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer
    Ghanghas, Preety
    Jain, Shelly
    Rana, Chandan
    Sanyal, S. N.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2016, 78 : 239 - 247
1234